PYC Therapeutics Ltd
PYC
Company Profile
Business description
PYC Therapeutics Ltd is a clinical-stage biotechnology company creating a new generation of RNA therapies for patients with genetic diseases. The Group is engaged in drug development and progressing the Company's drug pipeline through preclinical and clinical development. The Company operates in a single business segment comprising the discovery and development of novel RNA therapeutics, with a single geographical location in Australia.
Contact
6 Verdun Street
Harry Perkins Institute of Medical Research
Nedlands
PerthWA6009
AUST: +61 861510992
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
5
Stocks News & Analysis
stocks
Anthropic and OpenAI face commodification threats. Here’s what to watch for
Frontier AI labs face a three-pronged set of challenges.
stocks
Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment
We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,944.20 | 31.50 | -0.35% |
| CAC 40 | 7,840.29 | 27.76 | -0.35% |
| DAX 40 | 25,307.08 | 12.69 | -0.05% |
| Dow JONES (US) | 52,437.66 | 471.63 | 0.91% |
| FTSE 100 | 10,730.52 | 34.17 | -0.32% |
| HKSE | 23,867.74 | 319.09 | -1.32% |
| NASDAQ | 26,453.27 | 22.38 | 0.08% |
| Nikkei 225 | 64,075.42 | 841.28 | -1.30% |
| NZX 50 Index | 13,631.69 | 20.38 | -0.15% |
| S&P 500 | 7,713.23 | 22.50 | 0.29% |
| S&P/ASX 200 | 8,816.90 | 28.80 | -0.33% |
| SSE Composite Index | 3,735.37 | 4.45 | 0.12% |